Bram's talk focused on Practical Implications of the revised Annex 1 and more in particular on the impact on Visual Inspection and CCIT. Visual inspection, and especially the detection of particles, remains at the centre of many discussions regarding product compliance. Together with industry experts Bram discussed new regulatory requirements in the field of visual inspection, found in the latest draft of Annex 1. But also new developments such as the implementation of Artificial Intelligence and new approaches to project management for Visual Inspection. Find out more about PDA's Visual Inspection Forum here.
eyetec is one of the members of PDA Parental Drug Association. By bringing together industry, regulatory, and academic professionals from around the world to share science, technology, regulations, and new ideas, PDA contributes to the advancement of the ever-important bio/pharmaceutical manufacturing field.
Our next stop: PDA Parenteral Packaging Conference in Basel, Swiss, on 2 and 3 June. Visit eyetec at tabletop 36!
Want to receive Bram's presentation on Practical Implications of the revised Annex 1?